NIH-funded research Sbir 2 grant

Blood test to find dangerous brain aneurysms

Official title: Development of a Molecular Diagnostic to Identify Dangerous Intracranial Aneurysms

Funded at Neurovascular Diagnostics, INC. · NIH-11163352 · Data updated 2026-11-12

This project is creating a blood test to help doctors tell which people with brain aneurysms are more likely to have a dangerous rupture.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionNeurovascular Diagnostics, INC.
NIH-funded
Lab location1 site (Buffalo, United States)
Project startSeptember 30, 2019
Project endAugust 31, 2026
Funding year2025
Award (this year)$834,755
NIH project number5R44NS115314-04
Project IDNIH-11163352 on NIH RePORTER

Who could benefit from this research

Could help

Adults with an unruptured intracranial aneurysm found on imaging who are weighing whether to monitor or treat their aneurysm.

Less likely to help

People without aneurysms, those with a ruptured aneurysm needing emergency care, or patients unable to access participating centers may not benefit from this project.

What this research studies

If you have an unruptured brain aneurysm, this project is developing a blood test that looks for molecular signals linked to dangerous aneurysms. You may be asked to give a blood sample and share clinical information while researchers compare samples from people with stable aneurysms and those that proved high-risk. The team will use laboratory biomarker assays and computer algorithms to spot patterns that predict rupture risk without invasive angiography. The aim is a simpler, lower-risk test doctors can use alongside scans to guide treatment versus monitoring decisions.

Why it matters

Potential benefit: If successful, this could help avoid unnecessary procedures for low-risk aneurysms and speed treatment for those at high risk.

How similar studies have gone: Imaging-based risk scores exist, but blood-based tests to predict aneurysm rupture are mostly experimental and represent a relatively new approach.

Where this research is happening

  • Neurovascular Diagnostics, INC.
    Buffalo, United States
    Active

Researchers

  • Principal investigator: Poppenberg, Kerry — Neurovascular Diagnostics, INC.
  • Study coordinator: Poppenberg, Kerry

Related research

Other NIH-funded projects on the same topics.

  • Blood test to detect intracranial aneurysms and estimate risk in families

    A new blood test called AneuScreen+ aims to identify people at risk for brain aneurysms and predict rupture risk using a simple blood sample.

    NIH research Neurovascular Diagnostics, INC. · Buffalo, United States · NIH-11417233

  • Identifying dangerous brain aneurysms using blood tests

    This study is working on a new blood test to help doctors find dangerous brain aneurysms that might burst, making it easier and safer to decide which ones need urgent treatment and which can be watched over time.

    NIH research Neurovascular Diagnostics, INC. · Buffalo, United States · NIH-10912433

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.